Evidence map›Paper›PMID 41266806›Full record

ReviewCardiovascular and interventional radiology2026

Ablation Confirmation Software in Thermal Ablation of Liver Tumours: A Scoping Review of Contemporary Applications and Clinical Usability.

H H Schulz, A L Pos, S van der Lei, D J W Vos, M Dijkstra, F E F Timmer, G L Burchell, R S Puijk, G Laimer, R Bale and 2 more

Abstract readScoping ReviewReview
PubMed Publisher
In one paragraph

Review in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

H H SchulzDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. h.h.schulz@amsterdamumc.nl.
A L PosDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
S van der LeiDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
D J W VosDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
M DijkstraDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
F E F TimmerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
G L BurchellMedical Library, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
R S PuijkDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
G LaimerInterventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria.
R BaleInterventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Innsbruck, Austria.
C G OverduinDepartment of Medical Imaging, Radiology, Radboud UMC, Nijmegen, The Netherlands.
M R MeijerinkDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis scoping review presents an overview of available ablation confirmation (AC) software used during thermal ablation (TA) of liver tumours, focusing on features influencing clinical implementation.

methodsA systematic search in PubMed, Embase, and Web of Science identified studies reporting on local tumour progression (LTP) following TA using AC software for quantitative assessment of minimal ablative margins (MAM). Clinical usability was evaluated by scoring presence of data on ten predefined software features that could enhance clinical adoption, per software.

resultsOf 491 articles, 23 studies on 18 AC software tools were included. Most AC software was commercially available (13/18; 72%), of which 31% were non-dedicated software to liver ablation margin assessment. Clinical usability parameters were frequently underreported, with an average score of 4 out of 10.

conclusionAlthough clinical availability and evidence for AC software-based margin assessment are increasing, factors enhancing clinical usability are relatively poorly studied, limiting current clinical integration.

Indexed as

Ablation TechniquesCatheter AblationLiver NeoplasmsSoftwareHumansMargins of ExcisionAblation confirmation softwareAblation margin confirmationLiver tumoursLocal tumour progressionMinimal ablation marginThermal ablation

Identifiers

PMID41266806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.